XRTX
XORTX Therapeutics Inc.Company with tickers: XRTX
CIK
1729214
CUSIP
98420Q306
Shares Outstanding
1,730,565
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2024-08-22 | 2024-09-12 | |
| 6-K | 2024-08-23 | — | |
| 6-K | 2024-08-29 | — | |
| 6-K | 2024-09-04 | 2024-09-03 | |
| 6-K | 2024-09-06 | — | |
| 6-K | 2024-09-13 | 2024-09-12 | |
| 6-K | 2024-09-13 | — | |
| 6-K | 2024-10-09 | — | |
| 6-K | 2024-10-17 | — | |
| 6-K | 2024-10-18 | 2024-10-17 | |
| 6-K | 2024-10-18 | — | |
| 6-K | 2024-10-24 | — | |
| 6-K | 2024-11-15 | 2024-09-30 | |
| 6-K | 2024-12-12 | — | |
| 6-K | 2024-12-19 | — | |
| 6-K | 2025-01-06 | — | |
| 6-K | 2025-01-21 | 2025-01-17 | |
| 6-K | 2025-01-22 | 2025-01-21 | |
| 6-K | 2025-01-29 | — | |
| 6-K | 2025-02-24 | — | |
| 6-K | 2025-03-19 | — | |
| 6-K | 2025-03-26 | 2024-12-31 | |
| 6-K | 2025-04-01 | 2025-03-31 | |
| 6-K | 2025-04-18 | 2025-04-17 | |
| 6-K | 2025-04-28 | — | |
| 6-K | 2025-04-30 | — | |
| 20-F | 2025-05-12 | 2024-12-31 | |
| 6-K | 2025-05-16 | 2025-03-31 | |
| 6-K | 2025-05-19 | — | |
| 6-K | 2025-06-26 | — | |
| 6-K | 2025-08-07 | — | |
| 6-K | 2025-08-15 | 2025-06-30 | |
| 6-K | 2025-09-03 | — | |
| 6-K | 2025-09-04 | — | |
| 6-K | 2025-10-17 | — | |
| 6-K | 2025-10-21 | — | |
| 6-K | 2025-10-21 | 2025-10-20 | |
| 6-K | 2025-10-23 | 2025-10-22 | |
| 6-K | 2025-10-29 | — | |
| 6-K | 2025-10-31 | — | |
| 6-K | 2025-11-17 | 2025-09-30 | |
| 6-K | 2026-01-02 | 2025-12-31 | |
| 6-K | 2026-02-05 | 2026-02-04 | |
| 6-K | 2026-02-27 | 2025-12-31 | |
| 6-K | 2026-03-03 | — | |
| 6-K | 2026-03-05 | — | |
| 6-K | 2026-03-13 | — | |
| 6-K | 2026-03-19 | 2026-03-18 | |
| 20-F | 2026-03-20 | 2025-12-31 | |
| 6-K | 2026-03-24 | — |
Showing 101–150 of 160 filings